CARE vs BFST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

CARE

49.0
AI Score
VS
BFST Wins

BFST

50.8
AI Score

Investment Advisor Scores

CARE

49score
Recommendation
HOLD

BFST

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CARE BFST Winner
Net Income 31.36M 72.29M BFST
ROE 7.5% 7.2% CARE
ROA 0.6% 0.8% BFST
Total Assets 4.85B 8.96B BFST
Cash 105.16M 490.04M BFST
Free Cash Flow 31.81M 97.43M BFST

Relative Price Performance (Last 90 Days)

CARE 1M: -3.2% · 3M: -10.6% BFST 1M: +5.7% · 3M: +0.9%

Current Technical Phase

CARE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.9%), weak momentum, RSI 44

RSI (14): 43.8 · Price: $29.22

BFST

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 59

RSI (14): 58.7 · Price: $32.56

Fundamentals Snapshot

Metric CARE BFST
Market Cap — —
Forward P/E 11.7 9.9
Trailing P/E 5.0 11.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 1.0% 1.0%
Operating Margin 0.2% 0.4%
EPS 5.91 2.79
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, BFST is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.